Suppression of beta cell energy metabolism and insulin release by PGC-1alpha

J Cliff Yoon1, Gang Xu, Jude T Deeney

  • 1Dana-Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, Boston, MA 02215, USA.

Developmental Cell
|July 11, 2003
PubMed

Insights

Elevated PGC-1alpha in pancreatic beta cells impairs insulin secretion, contributing to type 2 diabetes. This molecular defect affects glucose metabolism and insulin release, highlighting PGC-1alpha

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Metabolic Diseases

Background:

  • Beta cell dysfunction is a key factor in type 2 diabetes pathogenesis.
  • The precise molecular mechanisms underlying beta cell dysfunction remain largely unknown.

Purpose of the Study:

  • To investigate the role of the transcriptional coactivator PGC-1alpha in beta cell function and its potential contribution to type 2 diabetes.

Main Methods:

  • Examined PGC-1alpha mRNA and protein levels in islets from diabetic animal models.
  • Utilized adenovirus-mediated expression of PGC-1alpha in isolated islets and live mice.
  • Analyzed changes in metabolic gene expression and insulin secretion.

Main Results:

  • PGC-1alpha levels were significantly elevated in islets of diabetic animal models.
  • Overexpression of PGC-1alpha inhibited glucose-stimulated insulin secretion.
  • Observed altered expression of key metabolic genes, including glucose-6-phosphatase, GLUT2, glucokinase, and glycerol-3-phosphate dehydrogenase.
  • Demonstrated blunted glucose-induced ATP production and impaired calcium influx, leading to reduced insulin exocytosis.

Conclusions:

  • PGC-1alpha plays a critical functional role in pancreatic beta cells.
  • Elevated PGC-1alpha is implicated in the pathogenesis of the diabetic phenotype by disrupting normal beta cell function and insulin secretion.

Related Concept Videos

Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.